A former top executive at Baxter International, who left in December after reports of disagreements with its chief executive, has signed on with a biotechnology firm.
James R. Tobin, 49, was named president and chief operating officer of Biogen, a Cambridge, Mass.-based firm with estimated revenues in 1993 of $150 million.
Biotechnology "is one of the most important and exciting areas in American business today," Mr. Tobin said.
Mr. Tobin resigned from Baxter reportedly after clashing with Baxter's chairman, Vernon R. Loucks Jr., about how far a restructuring of the giant hospital supply company should go (Jan. 3, p. 3).
Biogen's chief executive officer, James Vincent, left another Chicago-based healthcare supply company, Abbott Laboratories, in 1980 after disputes with its top executive.